Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German doctors cashing in on the dead:

This article was originally published in Clinica

Executive Summary

Germany's doctors have come under fire again for improper accounting. The regional subsidiary of the largest statutory health insurance fund, the AOK Niedersachsen, uncovered 140 cases in the last quarter of 2001 alone, in which doctors claimed treatment fees for dead patients. In one case a doctor in Wilhelmshaven claimed on behalf of 11 deceased patients. "On a national scale, we are talking about several thousand dead people, from whom doctors are profiting," Klaus Altmann, spokesperson for the AOK Niedersachsen, told NRD-Magazin Panorama. Federal health minister Ulla Schmidt said that she had contacted the federal association of statutory health insurance physicians in December concerning false accounting, but had received no reply. She added that such cases would cost the health service an extra E1bn ($1.1bn).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060781

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel